SCHEMBL8296456

SCHEMBL8296456

C[S+]([O-])c1ccc(C2=CC3(C=C2c2ccc(F)cc2)CC3)cc1

nearest known ligand 0.60

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 6/20 0.60
PTGS1 P23219 4/20 0.60
SIGMAR1 Q99720 2/20 0.32
DRD2 P14416 1/20 0.32
LPL P06858 1/20 0.31
LIPG Q9Y5X9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14485126 0.83 PTGS1 (0.41) PTGS2PTGS1LPLLIPG
SCHEMBL14467510 0.78 ACHE (0.41) LPLLIPG
SCHEMBL444633 0.78 ACHE (0.41) LPLLIPG
SCHEMBL213199 0.75 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL8295988 0.75 PTGS2 (0.58) PTGS2PTGS1
SCHEMBL6687073 0.72 PTGS2 (0.56) PTGS2PTGS1
SCHEMBL213440 0.72 PTGS2 (0.72) PTGS2PTGS1
SCHEMBL6913966 0.70 PTGS2 (0.86) PTGS2PTGS1
Sulfamide SCHEMBL4639646 0.69 PTGS1 (0.63) PTGS2PTGS1
SCHEMBL17907429 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005018541-A2 COX-2 INHIBITOR AND SEROTONIN MODULATOR FOR TREATING CNS DAMAGE PHARMACIA CORPORATION (US) 2005-03-03 WO disclosed
WO-2005009354-A2 COMPOSITIONS OF A CYCLOOXYGENASE-2 SELECTIVE INHIBITOR AND AN IKK INHIBITOR FOR THE TREATMENT OF ISCHEMIC-MEDIATED CENTRAL NERVOUS SYSTEM DISORDERS OR INJURY PHARMACIA CORPORATION (US) 2005-02-03 WO disclosed
WO-2004093814-A2 COMPOSITIONS OF A CYCLOOXYGENASE-2 SELECTIVE INHIBITOR AND A SODIUM CHANNEL BLOCKER PHARMACIA CORPORATION (US) 2004-11-04 WO disclosed
WO-2004093811-A2 COMPOSITIONS OF A CYCLOOXYGENASE-2 SELECTIVE INHIBITOR AND A SODIUM ION CHANNEL BLOCKER FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DAMAGE PHARMACIA CORPORATION (US) 2004-11-04 WO disclosed